Related Experiment Video
Updated: Jun 20, 2026
06:19
Label-Free Surface-Enhanced Raman Scattering Bioanalysis Based on Au@Carbon Dot Nanoprobes
Published on: June 9, 2023
Toward the development of "nano-QSARs": advances and challenges
Tomasz Puzyn1, Danuta Leszczynska, Jerzy Leszczynski
1Interdisciplinary Nanotoxicity Center, Department of Chemistry, Jackson State University, 1325 Lynch St, Jackson, MS 39217-0510, USA.
Small (Weinheim an Der Bergstrasse, Germany)
|September 30, 2009
Summary
Quantitative Structure-Activity Relationship (QSAR) models face challenges in nanomedicine risk assessment. Developing new descriptors and modeling nanoparticle classes separately is crucial for accurate safety evaluations.
Area of Science:
- Nanotechnology
- Toxicology
- Computational Chemistry
Background:
- Quantitative Structure-Activity Relationship (QSAR) is increasingly applied to nanomedicine risk assessment.
- Classical QSAR methods require adaptation for nanoscale materials due to unique properties.
Purpose of the Study:
- To highlight achievements and challenges in applying QSAR for nanometer-sized materials risk assessment.
- To review structural characterization methods and toxicological data applicability for QSAR model development.
Main Methods:
- Review of recent advances in QSAR methodology for nanomaterials.
- Evaluation of existing toxicological data for QSAR model creation.
- Presentation of current QSAR models for nanomedicine.
Main Results:
- Significant challenges exist in applying QSAR to nanometer-sized materials.
- Existing toxicological data has limited applicability for developing robust QSAR models.
- New interpretative descriptors are needed for nanosystems.
Conclusions:
- Individual nanoparticle classes require separate QSAR modeling due to structural variability and diverse toxicity mechanisms.
- Further development of QSAR approaches is essential for reliable nanomedicine risk assessment.
